
Managing diabetes in the time of the coronavirus
The outbreak of coronavirus disease 2019, or COVID-19 for short, has forced millions of people indoors and into isolation or quarantine.
A hypo is low blood sugars, low blood glucose.
Hypos are caused by insulin therapy and sulphonylureas.
In this section, we will provide some ideas for how to manage your
blood glucose to help you stay within your optimal blood glucose range
and reduce the risk of getting a low blood glucose level, which is
also called hypoglycaemia or a “hypo”.
“Hypos do not just affect you – it is important to also prepare your family for hypos”
The way you feel when your blood glucose level is low varies from person to person and may not be the same every time. You will soon learn to recognise your own early warning signs and how to take action.
If you experience any of the following symptoms you could
be having a hypo:
Do not delay in treating your hypo. Take some sugary food or drink as quickly as possible if you are conscious and can safely swallow. Try to take 15g of fast acting carbohydrate (unless instructed otherwise).
Remember to recheck your blood glucose after 15 minutes to reassure if blood glucose levels have recovered. More severe cases (if loss of consciousness occurs or a seizure happens) may require getting support from an emergency medical service. If a glucagon injection kit is available, it can be administered to manage severe hypos too.
The following are good options to treat a mild hypo:
If you are having difficulties in controlling your blood glucose levels and reducing the risk of hypos, you should seek the advice of your doctor or nurse.
To learn more about hypos, better understand why they appear and how to track and reduce the risk of getting hypos, we recommend you join the Hypo Program on www.hypoprogram.com.
This is general disease awareness and should not be understood as medical advice. If you experience symptoms of COVID-19 or have questions, doubts or concerns, you should contact your doctor. Always follow the advice of local authorities.
In this article you will find links to third-party material not owned or controlled by Novo Nordisk. We are not responsible for the content or the accuracy of the information provided and have no control over the privacy policies or terms of use of such third-party sites.
*are trademarks and are registered and protected by their respective owners.
Date of preparation: December 2022. IE22DI00182
The site you are entering is not the property of, nor managed by, Novo Nordisk. Novo Nordisk assumes no responsibility for the content of sites not managed by Novo Nordisk. Furthermore, Novo Nordisk is not responsible for, nor does it have control over, the privacy policies of these sites.